Ono discloses compounds with high binding affinity for prostanoid EP4 receptors Oct. 6, 1998 No Comments
Merck describes new ascomycin derivatives with improved therapeutic potential Oct. 5, 1998 No Comments
New study shows that LYMErix can be given according to a flexible dosing schedule Sep. 30, 1998 No Comments
Vertex issued first U.S. patent for IMPDH inhibitors, begins phase II trials of lead inhibitor Sep. 23, 1998 No Comments
RSS